Compare IMVT & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | RYN |
|---|---|---|
| Founded | 2018 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.4B |
| IPO Year | 2019 | 1994 |
| Metric | IMVT | RYN |
|---|---|---|
| Price | $33.39 | $20.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $33.00 | $26.00 |
| AVG Volume (30 Days) | 2.3M | ★ 2.4M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 11.73% |
| EPS Growth | N/A | ★ 26.78 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $484,485,000.00 |
| Revenue This Year | N/A | $214.97 |
| Revenue Next Year | N/A | $10.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.09 | $19.49 |
| 52 Week High | $36.29 | $27.34 |
| Indicator | IMVT | RYN |
|---|---|---|
| Relative Strength Index (RSI) | 63.49 | 53.58 |
| Support Level | $22.84 | $19.53 |
| Resistance Level | N/A | $21.62 |
| Average True Range (ATR) | 1.94 | 0.49 |
| MACD | 0.54 | 0.06 |
| Stochastic Oscillator | 72.62 | 61.92 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.